Cite
APA Citation
Lee, K., Kim, S., Sohn, J., Goodwin, A., Usari, T., Lanzalone, S., & Im, Y. (n.d.). 38OTalazoparib (TALA) vs physician's choice of chemotherapy (PCT) in Asian patients (Pts) with HER2- advanced breast cancer (ABC) and a germline BRCA1/2 mutation (gBRCA1/2mut): Data from phase III EMBRACA. Annals of oncology, 30, . http://access.bl.uk/ark:/81055/vdc_100098039900.0x00003b